|
ATXN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.08630004780741E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51629999667335E-08 |
| Normal-vs-Stage2 |
1.34949995622691E-09 |
| Normal-vs-Stage3 |
1.37469999827999E-08 |
| Normal-vs-Stage4 |
1.94460003655195E-09 |
| Stage1-vs-Stage2 |
1.094390E-01 |
| Stage1-vs-Stage3 |
6.404000E-01 |
| Stage1-vs-Stage4 |
2.050800E-01 |
| Stage2-vs-Stage3 |
2.748000E-01 |
| Stage2-vs-Stage4 |
7.303200E-01 |
| Stage3-vs-Stage4 |
3.838400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.85620002385912E-09 |
| Normal-vs-AfricanAmerican |
4.43559999999676E-05 |
| Normal-vs-Asian |
1.23190000000939E-06 |
| Caucasian-vs-AfricanAmerican |
1.663850E-01 |
| Caucasian-vs-Asian |
3.327400E-01 |
| AfricanAmerican-vs-Asian |
5.840200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.24410004310027E-09 |
| Normal-vs-Female |
6.82089995596158E-09 |
| Male-vs-Female |
5.911800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.33420000392582E-08 |
| Normal-vs-Age(41-60Yrs) |
4.70859995438389E-09 |
| Normal-vs-Age(61-80Yrs) |
8.1122997208638E-10 |
| Normal-vs-Age(81-100Yrs) |
1.943880E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.412800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.702200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.111600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.511200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.087800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.808000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.010000E-01 |
| Classical-VS-Follicular |
1.75865999999525E-05 |
| Classical-VS-Other |
3.916800E-01 |
| Classical-VS-Normal |
1.50790000041923E-07 |
| Tall-VS-Follicular |
1.015190E-01 |
| Tall-VS-Other |
7.466000E-01 |
| Tall-VS-Normal |
1.39860000025749E-07 |
| Follicular-VS-Other |
5.596800E-01 |
| Follicular-VS-Normal |
6.43259889798742E-11 |
| Other-VS-Normal |
8.117400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00260000301944E-09 |
| Normal-vs-N1 |
8.68909999507395E-09 |
| N0-vs-N1 |
7.819800E-01 |
|
|
